Episode 211: CAR T-Cell Therapy in RCC

By The Uromigos - Last Updated: January 3, 2023

Monty Pal, MD, FASCO, co-director of City of Hope’s Kidney Cancer Program and head of their kidney and bladder cancer disease team, discusses his recent study presented at the Society for Immunotherapy of Cancer’s 37th Annual Meeting. Dr. Pal’s study focuses on the use of novel CAR T-cell therapy for renal cell carcinoma.

Post Tags:Uromigos-Kidney Cancer
Advertisement
Advertisement